Trial Profile
TLC399 (ProDex) in Subjects With Macular Edema Due to Retinal Vein Occlusion (RVO)
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 25 Dec 2021
Price :
$35
*
At a glance
- Drugs Dexamethasone (Primary)
- Indications Retinal oedema
- Focus Therapeutic Use
- Sponsors Taiwan Liposome Company
- 16 Nov 2020 Status changed from active, no longer recruiting to completed.
- 14 Feb 2020 Planned End Date changed from 1 Jan 2020 to 1 Jun 2021.
- 14 Feb 2020 Planned primary completion date changed from 1 Dec 2019 to 1 Dec 2020.